| Factors | Arm → | TChT | ChT | Distortion (→TChT) | Pat Nr → | Nr | % | Nr | % | Δ% | Weight | Dist% | Impact ↓ | 169 | 49,6% | 172 | 50,4% |
| General factors | | | | | | | | | Tumor size | Reverse | 11 | | 11,3 | | 2,7% | 100% | 2,7% | Grade 3 | Reverse | 84 | 49,7% | 94 | 54,7% | 10,0% | 52% | 5,2% | Total | | | | | | 12,7% | | 7,9% |
| Chemotherapy | | | | | | | | | Number of ChT treated | Direct | 165 | 97,6% | 167 | 97,1% | 0,6% | 97% | 0,5% | Median number of cycles | Direct | 8 | | 5 | | 60,0% | 97% | 58,4% | Total | | | | | | 60,0% | | 59,0% |
| Surgery | | | | | | | | | Overall surgery (including previous) | Direct | 155 | 91,7% | 154 | 89,5% | 2,4% | 91% | 2,2% | Definitive surgery | Direct | 104 | 88,9% | 102 | 81,0% | 9,8% | 60% | 5,9% | Measurable disease without surgery | Reverse | 13 | 11,1% | 24 | 19,0% | 71,4% | 11% | 7,8% | R0 surgery + amputation | Direct | 60 | 35,5% | 51 | 29,7% | 19,7% | 33% | 6,4% | R1 surgery | Reverse | 35 | 20,7% | 36 | 20,9% | 1,1% | 21% | 0,2% | R2 surgery | Reverse | 9 | 5,3% | 14 | 8,1% | 52,8% | 7% | 3,6% | Total | | | | | | 154,9% | | 23,9% |
| Radiotherapy | | | | | | | | | Number of radiotherapies | Direct | 108 | 63,9% | 106 | 61,6% | 3,7% | 63% | 2,3% | Radiotherapy average dose | Direct | 53,2 | | 52,7 | | 0,9% | 63% | 0,6% | Total | | | | | | 4,6% | | 2,9% |
| TOTAL | | | | | | | | 93,7% |
|
|